Genomic Biomarker Testing

Information

Predictive biomarker assays (whole exome or RNA sequencing) qPCR or microarray-based RNA expression assays Gene expression profiles for detecting and characterizing mutations/biomarkers Comprehensive targeted NGS panels or tumor profiling assays to detect known and emerging biomarkers
Eurofins Viracor BioPharmaEurofins Viracor Biopharma has been a trusted provider of vaccine clinical development solutions to pharmaceutical sponsors  and contract research organizations for over 35 years; including 9 of the top 10 Global Pharma Companies. We are a team of highly experienced scientists and professionals, who excel at providing complex testing and assay development services for clinical research.  We further distinguish ourselves with a broad test menu, industry-leading technology platforms, and unique expertise in immunology, infectious disease, vaccine safety/efficacy, and cell and gene therapy studies. Our rigorous scientific and quality processes ensure that our clients get reliable, high quality data for better decision-making, faster development and smoother submissions. Whether assisting in fulfilling regulatory requirements for assessing immunogenicity, hypersensitivity and adverse immune stimulation, or in evaluating testing to aid with subject stratification, our scientists can help build the right assay to get the data you need.Viracor With over 2,800 validated tests available, Viracor Eurofins accepts a broad range of specimen types on over 15 different platforms, widening our capabilities and enabling us to customize to your study’s exact needs. Viracor Eurofins’ high-throughput clinical laboratory can support your trials with the automation required to process large sample volumes.  With short study set up timelines and rapid testing turnaround times, our project managers and scientists act as an extension of your team – going above and beyond to get you results.  Learn more at www.viracor-eurofins.com